Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Metastatic Germ Cell Tumor"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kah Poh Loh, Chunkit Fung
Publikováno v:
Rare Tumors, Vol 9, Iss 2 (2017)
Testicular germ cell tumor (GCT) is the most common malignancy in young males between the ages of 15 to 35 years. Although the overall cure rate of GCTs approaches 95%, almost 25% of patients with distant metastases die from the cancer. Active invest
Externí odkaz:
https://doaj.org/article/f53492f8c3644eb58de6302e00344481
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 998-1003 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 998-1003 (2021)
Although testicular germ cell tumors (GCTs) are known to curable disease even in cases with metastatic disease, patients in intermediate or poor-risk group may experience disease progression or refractory to the initial chemotherapy and needed second
Publikováno v:
Bulletin du Cancer. 107:S41-S48
More than 80 % of patient with metastatic germ cell tumor are cured with first line chemotherapy. Twenty to 30 % of patients will experience relapse or refractory disease with a very poor long-term prognosis. Most of them had metastatic germ cell tum
Autor:
Timothy A. Masterson, Lawrence H. Einhorn, Michal Chovanec, Nasser H. Hanna, Fadi Taza, Richard S. Foster, Nabil Adra, Clint Cary, Costantine Albany, Anna C. Snavely
Publikováno v:
J Clin Oncol
PURPOSE Presence of teratoma in patients with metastatic testicular germ cell tumor (GCT) is of unknown prognostic significance. We report survival outcomes of patients with or without teratoma in primary tumor and postchemotherapy retroperitoneal ly
Autor:
Ivana Dimkovski, Nebojša Stojanović, Žaklina Mijović, Boban Krstić, Miloš Kostov, Slađana Živković, Marko Dimitrijević
Publikováno v:
Acta Medica Medianae, Vol 50, Iss 3, Pp 45-48 (2011)
Testicular cancer is a rare disease of younger men, but the incidence of this disease has increased considerably in the recent years in many western countries. Ninety-five percents of these tumours derive from germinative cells, and more than 70% of
Externí odkaz:
https://doaj.org/article/e47d92f461de4ad1a12509c0dd3c7b21
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Thoracic and Cardiovascular Surgery
Germ cell tumors (GCTs) are the most common malignancy among young men in the United States. Although prognosis is favorable and response to cisplatin-based chemotherapy regimens is good, 10%–20% of patients with thoracic metastases require surgica
Autor:
Xavier Garcia del Muro, Alexey Tryakin, Anis A. Hamid, Daniel Castellano, Philippe L. Bedard, Enrique Gonzalez-Billalabeitia, Anna Patrikidou, Tina Cheng, Giovannella Palmieri, Carsten Bokemeyer, Robert Kitson, Christian D. Fankhauser, Christoph Seidel, Edmond M. Kwan, Margarida Brito, Margaret Ottaviano, Aude Flechon, Thomas Hermanns, Daniel Y.C. Heng, Eitan Amir, Jose Manuel Ruiz-Morales, Alison Reid, Alexey Rumyantsev, Ben Tran
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 116-124 (2020)
Cancer Medicine
Cancer Medicine
Background Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life‐threatening venous thromboembolism (VTE). Identifying VTE risk factors may guide thromboprophylaxis in this highly curable population. Methods
Autor:
Axel Heidenreich, Tim Nestler, David Pfister, Maike Wittersheim, Lara Kremer, Pia Paffenholz, Melanie von Brandenstein, Martin Hellmich, Barbara Koeditz
Publikováno v:
Transl Androl Urol
BACKGROUND: To identify a combination of microRNAs (miRNA) to differentiate between viable tumor (V) or teratoma (T) and necrosis/fibrosis (N) in pcRPLND specimens of metastatic germ cell tumor (GCT) patients with residual masses ≥1 cm after chemot